Basic Information
Xphera Biosciences is a biotechnology company dedicated to bridging the translational gap between animal models for cancer treatment and human clinical trials. Through collaboration with Dana-Farber, Xsphera has developed a revolutionary platform based on fresh human tumor tissue that can evaluate the efficacy of various cancer indications and drug modalities. By combining this in vitro biological capability with its AI cloud analytics platform, Xsphera can uncover potential mechanisms of action and drug resistance within the tumor microenvironment, providing valuable insights into human biology and clinical trial strategies.
Xsphera Biosciences Inc.
Boston,Massachusetts,United States of America
15~50 people
October 01, 2018
sales@xspherabio.com.
